Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal UIMC1 Primary Antibody for EIA, IHC (p) - ABIN500567
Kim, Huang, Chen: CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. in Nature structural & molecular biology 2007
Show all 4 references for ABIN500567
Human Polyclonal UIMC1 Primary Antibody for EIA, IHC (p) - ABIN500569
Liu, Wu, Yu: CCDC98 targets BRCA1 to DNA damage sites. in Nature structural & molecular biology 2007
Show all 4 references for ABIN500569
Human Polyclonal UIMC1 Primary Antibody for ICC, IF - ABIN250739
Yan, Kim, Yang, Li, Liao, Xia, Jetten: The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response. in Cancer research 2007
Show all 3 references for ABIN250739
Human Polyclonal UIMC1 Primary Antibody for ICC, IF - ABIN4349369
Lin, Ratner, Whicker, Lee, Sartorelli: Triapine disrupts CtIP-mediated homologous recombination repair and sensitizes ovarian cancer cells to PARP and topoisomerase inhibitors. in Molecular cancer research : MCR 2014
Show all 3 references for ABIN4349369
Human Polyclonal UIMC1 Primary Antibody for WB - ABIN1944736
Yan, Kim, Jetten: RAP80, a novel nuclear protein that interacts with the retinoid-related testis-associated receptor. in The Journal of biological chemistry 2002
Show all 3 references for ABIN1944736
Dog (Canine) Polyclonal UIMC1 Primary Antibody for ELISA, ICC - ABIN4349366
Nikkilä, Coleman, Morrissey, Pylkäs, Erkko, Messick, Karppinen, Amelina, Winqvist, Greenberg: Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function. in Oncogene 2009
Low RAP80 mRNA expression correlates with sporadic high-grade serous ovarian carcinoma.
RAP80 is a critical gatekeeper in impeding epithelial-mesenchymal transition-induced metastasis and malignant phenotypes of cancer as well as preserving DNA integrity.
Data suggest that RAP80 SIM (show SIM2 Antibodies) (SUMO interacting motif) binds SUMO-2 (show SUMO2 Antibodies); both specificity and affinity are enhanced through phosphorylation of canonical CK2 (show CSNK2A1 Antibodies) (casein kinase 2) site within the SIM (show SIM2 Antibodies).
Impaired TIP60 (show KAT5 Antibodies)-mediated H4K16 acetylation accounts for the aberrant chromatin accumulation of 53BP1 (show TP53BP1 Antibodies) and RAP80 in Fanconi anemia (show PALB2 Antibodies) pathway-deficient cells.
TRAIP/RNF206 (show TRAIP Antibodies) is required for recruitment of RAP80 to sites of DNA damage.(
A new role of FANCG in Homologous recombination repair of interstrand crosslinks through K63Ub-mediated interaction with the Rap80-BRCA1 complex.
patients with low RAP80 expression received gemcitabine/cisplatin, those with intermediate/high RAP80 expression and low/intermediate BRCA1 expression received docetaxel/cisplatin
Data indicate that a single point deletion (DeltaE81) in RAP80 abrogates multivalent interactions with polyubiquitin (show UBB Antibodies).
connect ubiquitin- and SUMO-dependent DSB recognition, revealing that RNF4-synthesized hybrid SUMO-ubiquitin chains are recognized by RAP80 to promote BRCA1 recruitment and DNA repair.
post-translational phosphorylation of RAP80 by the Cdk1 (show CDK1 Antibodies)-cyclin B(1) complex is important for RAP80 functional sensitivity to IR and G(2)/M checkpoint control.
Data indicate that RAP80-deficiency promotes genomic instability and causes an increase in cancer risk consistent with the concept that RAP80 exhibits a tumor suppressor function.
a model in which SUMO and Ub modification is coordinated to recruit Rap80 and BRCA1 to DNA damage sites.
Mechanistically, loss of RAP80 suppresses recruitment of the BRCA1-A complex to DNA damage sites and abrogates the DNA damage repair process at DNA damage sites.
Both ubiquitin-interacting motif 1(UIM1) and UIM2 of RAP80 recognize an Ile 44-centered hydrophobic patch on ubiquitin but neither UIM interacts with the Lys (show LYZ Antibodies) 63-linked isopeptide bond. [RAP80]
Ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B\; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly Act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1 (By similarity).
ubiquitin interaction motif containing 1
, BRCA1-A complex subunit RAP80-like
, BRCA1-A complex subunit RAP80
, receptor-associated protein 80
, ubiquitin interaction motif-containing protein 1
, receptor associated protein 80
, retinoid X receptor-interacting protein 110
, retinoid x receptor interacting protein
, retinoid X receptor interacting protein 110